DURECT Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company announced the update on DUR-928 development program in the following press release.
“These recent DUR-928 data in patients are consistent with DUR-928 activities previously demonstrated in animal models and in cell cultures. Additionally, we are reporting on two new animal studies that are suggestive of DUR-928’s potential therapeutic activities in fibrotic and cholestatic liver diseases, and are preparing two IND’s to enable future clinical trials in the U.S,” stated James E. Brown, D.V.M., President and CEO of DURECT. Read the full article.
DURECT Corp. operates as a biopharmaceutical company. It engages in the development of therapeutics based on its proprietary drug delivery technology platforms. Its brands include ALZET, a osmotic pumps, which is used in laboratory research; and LACTEL, a biodegradable polymers, which is used by pharmaceutical and medical device clients for use as raw materials in their products. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA. [Source: MarketWatch]
Company Website: http://www.durect.com